Advertisement

Topics

Daiichi Sankyo Selects Deloitte's ConvergeHEALTH Safety To Transform And Upgrade Global Drug Safety Platform

11:30 EDT 21 Jun 2017 | eCliniqua

Clinical Informatics News Brief | Deloitte has announced the debut of a global initiative to launch an innovative integrated solution for the pharmacovigilance capabilities of Daiichi Sankyo.


 
 
 
 

Original Article: Daiichi Sankyo Selects Deloitte's ConvergeHEALTH Safety To Transform And Upgrade Global Drug Safety Platform

NEXT ARTICLE

More From BioPortfolio on "Daiichi Sankyo Selects Deloitte's ConvergeHEALTH Safety To Transform And Upgrade Global Drug Safety Platform"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...